Real-world Outcomes of Dual HER2 Blockade Therapy in Metastatic HER2-Positive Breast Cancer: from Induction to Maintenance.

Marija KrižićMarina PopovićTajana SilovskiDorotea GrbinNatalija Dedić Plavetić

Published in: Drugs - real world outcomes (2024)

This retrospective study provides additional data on patient characteristics, treatment and outcomes of RW HER2-positive mBC patients treated with pertuzumab and trastuzumab as first-line therapy. In our institution, maintenance ET after induction Cht has become standard clinical practice.

Keyphrases

positive breast cancer
clinical practice
epidermal growth factor receptor
squamous cell carcinoma
small cell lung cancer
case report
metastatic breast cancer
stem cells
big data
machine learning
metabolic syndrome
adipose tissue
skeletal muscle
bone marrow
cell therapy
weight loss
tyrosine kinase